arvo run..., page-14

re: arvo run...but what lies tomoro? Interesting announcement. I hold shares in a US co. called Amylin Pharmaceuticals which is doing phase 3 trials for a competing diabetes treatment. The treatment that DIA is working on sounds like it has major advantages in terms of rapid absorption and hypoglycemic reaction.

I know everyone thinks a little ozzie co. can't compete but it's all about the brains behind an outfit and the research being conducted at Monash is a potential world beater imo.

Oh and one other thing... Amylins market cap is over 4b!